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The discovery that the mammalian brain
contains neural stem cells, and that
such cells produce new neurons during
adulthood through a process known as
“adult neurogenesis,” led to the hypoth-
esis that their underlying biology could
be exploited for central nervous system
(CNS) repair purposes. Yet, in spite of
the large amount of knowledge gathered
on adult neurogenesis during the last
two decades, no substantial translational
advances have been reached for most neu-
rological diseases (Rossi and Cattaneo,
2002; Arenas, 2010; Lindvall and Kokaia,
2010). This may be linked to the intrin-
sic complexity of the nervous tissue at the
structural, developmental, and evolution-
ary level, that preclude cell regeneration
and repair (Weil et al., 2008; Bonfanti,
2011). As a result, neural cell replace-
ment is at present not possible neither
by implementation of endogenous neuro-
genic potential nor through transplanta-
tion of highly neurogenic stem cell sources.
However, in the gold rush-like phe-
nomenon that has followed the discovery
of neural stem cells the scientific commu-
nity appeared often unaware of the limits
associated with endogenous cell replace-
ment and underestimated some problems
and hurdles, which remain unknown to
the general public and are sometimes
undetected by the scientists themselves.
In addition, the misleading communica-
tion of a series of basic scientific results
that are often biased toward their possible
translation, along with an amplification of
interpretation from the media to the pub-
lic have led to the perception that new
therapeutic “possibilities” were at reach.
What has been missed is a real vision of
the state of the art: the present inabil-
ity of medical science and fundamental
research to overcome the gap between
in vitro stem cell behavior and their adap-
tation to brain environment, as well as
the need of more fundamental research
prior to proposing therapeutic perspec-
tives. As a consequence, the complex inter-
mix emerging from stem cell discoveries,
scientists’ press releases, media, and soci-
ety has produced substantial failure in the
communication of scientific results, ulti-
mately putting pressure toward premature
translation of still insufficient pre-clinical
data. In this Opinion article we suggest
that a better communication from scien-
tists to the public, without distortion by
media and scientists themselves, is needed
to avoid misunderstanding and to increase
trust and constructive dialogue between
science and society.
STEM CELL DISCOVERIES, ADULT
NEUROGENESIS, AND THE
TRANSLATIONAL GAP
Since the beginning of the nineties, the
fact that adult neurogenesis can occur in
mammals, at least within certain brain
regions, led many scientists to exploit this
endogenous capacity of the CNS for repar-
ative/regenerative strategies. In parallel,
several attempts have been put in place to
bring the neural stem/progenitor cells in
a dish or to obtain them from pluripo-
tent stem cells. Yet, very small advances in
the translation of this knowledge toward
brain repair have been achieved. Many
breakthroughs have been obtained in cul-
ture systems, thus increasing our ability to
grow and manipulate stem cells (from the
old neurosphere assay to the most strik-
ing example of the induced pluripotent
stem cells—iPS—from the Yamanaka lab
or of the direct reprogramming strategy).
Yet, what hampers the possible therapeu-
tic exploitation of stem/progenitor cells is
a gap of knowledge between their activ-
ity/product and the host tissue environ-
ment. Paradoxically, the discovery of adult
neurogenesis as a process which destroys
the dogma of a static brain also shows
that the exceptions are restricted to small
neurogenic sites. Moreover, spontaneous
neurogenesis in adult mammals is primar-
ily linked to homeostatic roles and hardly
directed to repair (Bonfanti, 2011). In
other words, endogenous stem cells work
well in their niches as do isolated stem cells
in vitro, both sources of progenitors fail-
ing to properly act in the mature nervous
tissue (normal and pathological). Hence,
particularly in the CNS, unlike tissues
that undergo continuous cell renewal (e.g.,
skin, blood, etc.), it is not granted that
the goal of brain repair could be solved
by gaining additional knowledge and/or by
improving the availability of highly neuro-
genic stem cell sources.
Today, excellent protocols have been
developed that recapitulate human brain
development in vitro starting from human
embryonic stem cells or human iPS cells.
In the most extraordinary achievement,
authentic dopaminergic neurons have, for
the first time, been obtained which are
capable of persistent functional recovery
when transplanted into a mouse and rat
model of Parkinson’s disease (Kriks et al.,
2011). In spite of such progress, it is still
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unclear how these cells which are highly
plastic in culture systems may function
and persist long-term in vivo and whether
a permanent reconstruction of damaged
brain circuits in adulthoodmay be realistic
(Rossi and Cattaneo, 2002). Furthermore,
quite surprisingly, in the large literature on
adult neurogenesis and neural stem cells
there are a few reports analyzing the factors
hampering brain repair following the use
of exogenously delivered and/or endoge-
nous stem/progenitor cells; most studies
are focused on the other side of the coin,
e.g., the factors promoting neurogenesis.
While pursuing the cell replacement
strategy, a further therapeutic approach
might be that of exploiting the neuropro-
tective and immune modulatory capaci-
ties of both transplanted (Martino et al.,
2011) and endogenous (Kokaia et al.,
2012) stem/progenitor cells. Yet, the recent
discovery of such “bystander effect” fore-
seeing transplanted cells as biological
minipumps able to release beneficial fac-
tors, although promising under the profile
of research, can be a further source of
confusion between scientists, physicians,
and patients. At the present time, more
than 300 clinical trials have been started
in the world to test the effect(s) of differ-
ent stem cell sources in neurodegenerative
diseases (Donegà et al., 2013). In most
cases, little is known about the mecha-
nisms by which different stem cell lines
are expected to function in vivo, what is
their survival and distribution, what are
the beneficial (rather than detrimental)
factors they release, whether their release is
sustained over time or, rather, represent an
acute reaction after transplantation which
may vanish at prolonged survival times,
and which aspect of the neuropathology is
expected to be targeted.
In conclusion, it is our perception that
the translation of basic knowledge discov-
eries on both endogenous and exogenous
stem cells into robust, biologically, and
therapeutically relevant cell-based strate-
gies for neurological diseases still remains
a far-reaching goal which requires fur-
ther years of research, possibly with the
notable exception of Parkinson’s disease.
In parallel, current adult neurogenesis
research, although largely not tailored
toward restoration and regeneration,
might yield new perspectives through
insight into fundamental principles of
plasticity and particular roles of new
neurons in the brain, most notably in
the hippocampus (Kheirbek et al., 2012;
Snyder and Cameron, 2012; Freund et al.,
2013). Yet, when communicating science, a
clear distinction should be made between
translational perspectives having indirect
implications for our understanding of
aging and brain disease, and those directed
at obtaining cell replacement goals.
STEM CELL DISCOVERIES: SCIENTISTS,
MEDIA, AND SOCIETY
As for many other fields, the stem cell
arena has been characterized by repeated
breakthroughs resulting in the public per-
ception that “stem cells” act likemagic bul-
lets that can cure many diseases. Because
of this high level of expectation, it has
become increasingly difficult to maintain
a balance between crude reality, realistic
perspectives, and unjustified hopes. This
failure in the dissemination of complex
scientific concepts depends on the actions
carried out by people bringing different
kinds of responsibilities at various levels
of the communication process. In partic-
ular, during the communication process, a
number of significant steps may be over-
looked as follows: (i) the original commu-
nication of the results obtained within the
scientific community (scientific papers) is
often too unbalanced toward the possi-
ble translation of basic science discover-
ies; (ii) there is an overemphasized release
of information concerning the publication
of a paper to the media; (iii) the above
is followed by an amplification of inter-
pretation/communication from the media
to the public (which always stresses the
“possible”—but at present non-existing—
therapeutic use of a new discovery with-
out paying any attention to the discovery
process and to the value of the knowledge-
acquisition process); (iv) patients and/or
their families are often exposed to sim-
plified interpretations of new therapeutic
“possibilities”; (v) there is frequent mis-
understanding about the real role of clin-
ical trials in ascertaining the effectiveness
and security of a given cell-based strat-
egy; (vi) the recent description of the so
called “bystander effect” has become a fur-
ther source of overestimation of stem cell
potential by incompetent physicians.What
is not clearly perceived is the inability of
medical science and fundamental research
to overcome the gap between stem cell
potential to regenerate new neurons and
the non-permissive CNS environment pre-
venting cell integration. Ultimately, a gen-
eral thinking has prevailed supporting the
view that stem cell treatments can produce
new neurons in the diseased brain or that
the bystander effects of given stem cells are
already “therapies.”
A consequence of such misunderstand-
ing has been particularly deleterious in
Italy, where last year political decisions
have led to the authorization by the
Parliament of the first governmental spon-
sored clinical trial intended to evaluate
an unverified cell-based “treatment.” This
treatment was without a scientific basis,
ineffective, and dangerous. Such a deci-
sion has been taken under the pressure of
a small group of protesting lay people and
patients without involving scientists and
experts in the field. The State-sponsored
trial has been stopped by the current
Ministry of Health on the basis of a neg-
ative evaluation by an ad hoc appointed
scientific committee. However, as we write,
a regional court declared that commit-
tee unlawfully biased, and a new commit-
tee has now been nominated. Protesters
and patients, however, are still in tri-
bunals, several of them having autho-
rized the injection of the same, unproven,
unknown, and ill-prepared “stem cell
potion” into people with diseases as
severe as Parkinson, Amyotrophic Lateral
Sclerosis, Spinal Muscular Atrophy, or
even coma on the basis of a “constitutional
right for a cure.”
CONCLUSIONS AND POSSIBLE
SOLUTIONS
There are several gaps and distortions
in the process of science communication
on regenerative medicine in general—and
for neurological diseases in particular—
that can lead to serious abuses, misunder-
standing, and heavy consequences for the
patient’s life. It is necessary to address such
issues in the future by identifying the sin-
gle steps and responsibilities in order to
prevent/overcome the problem. One pos-
sible solution might be the introduction of
an additional regulation of stem cell thera-
pies, as suggested in a recent paper (Bianco
et al., 2013): “The scientific community
must consider the context—social, finan-
cial, medical, legal—in which stem cell
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science is currently situated and the need
for stringent regulation. Additional con-
cerns are emerging. These emanate from
the novel climate, created within science
itself, and stem cell science in particular, by
the currently prevailing model of “trans-
lational medicine.” Only rigorous science
and rigorous regulation can ensure trans-
lation of science into effective therapies
rather than into ineffective market prod-
ucts, andmark, at the same time, the sharp
distinction between the striving for new
therapies and the deceit of patients.”
Yet, such a remedy might be ineffective
in the absence of a more direct involve-
ment of scientists into the communica-
tion process. In this context, the biological
issues involved in the process of adult
neurogenesis viewed as an in vivo prod-
uct of neural stem cell activity, are even
more tight to be grasped. The different
ways by which spontaneous and/or lesion-
induced neurogenic plasticity might be
exploited for therapeutic strategies must
be clearly explained to the public, as well
as it should be made clear that long-term
efforts are required to test how effective
such strategies might be. Recently, the neu-
roscientist David M. Eagleman focused
on the dilemma: “Communicating science
to the public takes time away from busy
research careers. So why would you do it?”
(Eagleman, 2013). His answer consisted
of six reasons which embrace the whole
meaning of science and its beauty, from
the need to acknowledge the funders, to
stopping the flow of bad information, to
the need of clarifying what science is and
is not. These tasks should remain within
the responsibilities of scientists themselves
because that is exactly what they are “well
set up for.”
ACKNOWLEDGMENTS
We thank Angelique Bordey for read-
ing the manuscript and for her precious
advices.
REFERENCES
Arenas, E. (2010). Towards stem cell replace-
ment therapies for Parkinson’sdisease. Biochem.
Biophys. Res. Commun. 396, 152–156. doi:
10.1016/j.bbrc.2010.04.037
Bianco, P., Barker, R., Brustle, O., Cattaneo, E.,
Clevers, H., Daley, G. Q., et al. (2013). Regulation
of stem cell therapies under attack in Europe: for
whom the bell tolls. EMBO J. 32, 1489–1495. doi:
10.1038/emboj.2013.114
Bonfanti, L. (2011). From hydra regeneration to
human brain structural plasticity: a long trip
through narrowing roads. Sci. World J. 11,
1270–1299. doi: 10.1100/tsw.2011.113
Donegà, M., Giusto, E., Cossetti, C., and Pluchino,
S. (2013). “Systemic neural stem cell-based ther-
apeutic interventions for inflammatory CNS dis-
orders,” in Neural Stem Cells: New Perspectives, ed
L. Bonfanti (Rijeka: INTECH), 287–347.
Eagleman, D. (2013). Why public dissemination
of science matters: a manifesto. J. Neurosci.
33, 12147–12149. doi: 10.1523/JNEUROSCI.2556-
13.2013
Freund, J., Brandmaier, A. M., Lewejohann, L.,
Kirste, I., Kritzler, M., Krüger, A., et al. (2013).
Emergence of individuality in genetically identi-
cal mice. Science 340, 756–759. doi: 10.1126/sci-
ence.1235294
Kheirbek, M. A., Klemenhagen, K. C., Sahay, A.,
and Hen, R. (2012). Neurogenesis and generaliza-
tion: a new approach to stratify and treat anxi-
ety disorders. Nat. Neurosci. 15, 1613–1620. doi:
10.1038/nn.3262
Kokaia, Z., Martino, G., Schwartz,M., and Lindvall, O.
(2012). Cross-talk between neural stem cells and
immune cells: the key to better brain repair? Nat.
Neurosci. 15, 1078–1087. doi: 10.1038/nn.3163
Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman,
D. R., Xie, Z., et al. (2011). Dopamine neurons
derived from human ES cells efficiently engraft in
animal models of Parkinson’s disease. Nature 480,
547–551. doi: 10.1038/nature10648
Lindvall, O., and Kokaia, Z. (2010). Stem cells in
human neurodegenerativedisorders-time for clin-
ical translation? J. Clin. Invest. 120, 29–40. doi:
10.1172/JCI40543
Martino, G. V., Pluchino, S., Bonfanti, L., and
Schwartz, M. (2011). Brain regeneration in phys-
iology and pathology: the immune signature driv-
ing therapeutic plasticity of neural stem cells.
Phys. Rev. 91, 1281–1304. doi: 10.1152/phys-
rev.00032.2010
Rossi, F., and Cattaneo, E. (2002). Neural stem
cell therapy for neurological diseases: dreams
and reality. Nat. Rev. Neurosci. 3, 401–409. doi:
10.1038/nrn809
Snyder, J. S., and Cameron, H. A. (2012).
Could,adult,hippocampal,neurogenesis be rele-
vant for human behavior? Behav. Brain Res. 14,
384–390. doi: 10.1016/j.bbr.2011.06.024
Weil, Z. M., Norman, G. J., DeVries, A. C., and
Nelson, R. J. (2008). The injured nervous system: a
Darwinian perspective. Prog. Neurobiol. 86, 48–59.
doi: 10.1016/j.pneurobio.2008.06.001
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 25 February 2014; accepted: 31 March 2014;
published online: 16 April 2014.
Citation: Cattaneo E and Bonfanti L (2014)
Therapeutic potential of neural stem cells: greater
in people’s perception than in their brains? Front.
Neurosci. 8:79. doi: 10.3389/fnins.2014.00079
This article was submitted to Neurogenesis, a section of
the journal Frontiers in Neuroscience.
Copyright © 2014 Cattaneo and Bonfanti. This is an
open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is per-
mitted, provided the original author(s) or licensor are
credited and that the original publication in this journal
is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which
does not comply with these terms.
www.frontiersin.org April 2014 | Volume 8 | Article 79 | 3
